XML 18 R5.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Mar. 31, 2018
Mar. 31, 2017
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (1,827,419) $ (3,602,096)
Adjustments to reconcile net loss to net cash (used in) operating activities    
Depreciation and amortization 30,462 41,411
Issuance of capital stock for services and expenses 70,641 376,989
Conversion of interest 64,233 87,694
Stock based compensation 7,334 21,774
Gain (loss) on sale of assets 0 (1,034)
Loss on change - derivative liability 0 1,222,555
Amortization of debt discount 475,174 10,500
Conversion of accrued liabilites- related parties to convertible notes payable 491,802 0
Provision on loss on accounts receivable 21,406 120,000
Issuance of warrant for debt conversion 110,545 0
Impairment of goodwill 0 983,645
Changes in operating assets and liabilities:    
Accounts receivable 114,918 (51,533)
Prepaid expenses 4,292 963
Inventory 21,616 58,669
Other assets (2,100) 0
Accounts payable - trade and accrued expenses 33,193 161,883
Deferred revenue (58,615) 0
NET CASH (USED IN) OPERATING ACTIVITIES (442,518) (568,580)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Investment in BioMedx, Inc., net 0 (260,000)
Proceeds from investment in BioMedx, Inc, 0 290,608
Proceeds from sale of equipment 0 1,034
NET CASH PROVIDED BY INVESTING ACTIVITIES: 0 31,642
CASH FLOWS FROM FINANCING ACTIVITIES:    
(Repayments) from line of credit (190,663) (4,781)
Proceeds from convertible notes payable 530,000 330,000
Repayment of convertible notes 0 (125,000)
Proceeds from issuance of common/preferred stock, net of costs 0 300,000
NET CASH PROVIDED BY FINANCING ACTIVITIES 339,337 500,219
NET (DECREASE) IN CASH AND CASH EQUIVALENTS (103,181) (36,719)
CASH AND CASH EQUIVALENTS, beginning of period 103,181 188,309
CASH AND CASH EQUIVALENTS, end of period 0 151,590
Supplemental disclosures of cash flow information:    
Interest paid 20,243 14,245
Taxes paid 0 0
Non-cash investing and financing activities:    
Benificial conversion feature 348,096 0
Conversion of convertible debt 0 695,000
Benificial conversion feaature 0 559,130
Conversion of conertible debt to preferred shares 0 220,000
Related party accounts converted to notes $ 482,014 $ 0